By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Point-of-care diagnostics (POCD) are critical in the healthcare industry. Point of Care (POC) testing is medical diagnostic testing that is done outside of the clinical laboratory and near to where the patient is receiving care.
It is often carried out by non-laboratory workers, and the results are utilised to make clinical decisions.
It has attracted substantial attention throughout time for quick detection of numerous life-threatening or infectious disorders such as cancer, diabetes, and infectious diseases, as well as monitoring patients’ health problems
but Factors such as increased illness incidence, which leads to a rise in demand for improved treatment and quick diagnostic services, and clinical laboratory personnel shortages are driving the demand for POC diagnostics.
The India Point Of Care (POC) Diagnostics Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.
Mylab Discovery Solutions announced, a collaboration with Hemex Health of the United States to create next-generation diagnostic solutions for point-of-care (POC) testing of coronavirus and other illnesses.
Point-of-care testing, in general, refers to any tests done on a patient at the place where care or treatment is administered, with findings often accessible very rapidly.
According to a joint release, Mylab will design test assays and Hemex will supply its Gazelle POC testing platform and expertise as part of the technical agreement.
The portable diagnostic gadget and tests assays will aid in testing at any place, in a variety of environmental conditions, and without the need to carry the sample, allowing patients to receive findings quickly.
In Mumbai, India, Hipro and Affimedix hosted a presentation of the Hipro product. In the conference, Hipro and Affimedix announced the launch of their world-class point-of-care diagnostic products in India, including the Hipro SimplyRead line of IVD reagents and AUTO POCT-Lab Analyzers.
The president of Hipro gave a thorough overview of the company and its Accurate POC equipment to the distributors. The attendees all gave Hipro’s Accurate goods and design ideas high acclaim. The Hipro Indian market was stimulated by this debut event, which also signalled the beginning of the Hipro global market.
A majority share in Sanskritech, creator of the platform Swayam, a point-of-care testing system, has been acquired by Mylab Discovery Solutions. Sanskritech has created the Swayam point-of-care testing platform, which can perform 70 tests right away. The Swayam platform provides a telemedicine facility in addition to covering 70 test criteria.
Through laboratory partners, Mylab will now set up PoC testing devices at doctor’s offices, nursing homes, community health centres, airports, etc.
